Clonal hematopoiesis and clinical outcomes in metastatic castration-resistant prostate cancer patients given androgen receptor-pathway inhibitors (Alliance A031201)
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 30 (21) 4910-9
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
15
Parents:
3975  
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
Astellas  
Grants:
U10CA180821, U10CA180882, U24 CA196171, UG1CA233253, UG1CA233290, UG1CA233180, UG1CA233339, UG1CA233373  
Corr. Author:
 
Authors:
                           
Networks:
CA088, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NC010, LAPS-NY016   
Study
Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: